NeuroTek Medical is an emerging device company developing non-invasive, electronic neuromodulation devices for the treatment of a variety of pathologies. Our founders have been a part of nearly $30M in active medical device development. Key personnel are inventors on 20+ patents and applications and own 15 issued patents in the medical device space.
Currently, NeuroTek is developing a battery-operated, self-administered home-based device that can safely and transcutaneously stimulate the occipital nerve for treating migraines. TONES is a non-surgical, non-drug based solution that is a cost-effective option for immediate relief at the onset of a migraine. Migraine headache pain is a serious debilitating condition affecting more than 10% of the population, with accepted figures of 30 million sufferers in the US and 240 million worldwide. NeuroTek's goal is to provide an alternative treatment option to the 50% of episodic migraineurs who are dissatisfied with their current therapy.